COYA
Coya Therapeutics·NASDAQ
--
--(--)
--
--(--)
COYA Filings
Filing Date
Form Description
Form Type
2026-03-23
Form EFFECT - Notice of Effectiveness
2026-03-23 ·
Form EFFECT - Notice of Effectiveness
2026-03-20
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-20 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-16
Form S-3 - Registration statement under Securities Act of 1933
2026-03-16 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-03-16
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-16 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-16
Form 8-K - Current report
Key Events
2026-03-16 · Key Events
Form 8-K - Current report
2026-03-12
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-12 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30
Form 8-K - Current report
Key Events
2026-01-30 · Key Events
Form 8-K - Current report
2026-01-28
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-28 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
